Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference

▤ Summary

Royalty Pharma announced that it will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. The company describes itself as a major buyer of biopharmaceutical royalties and a funder of innovation across the life sciences industry. Its business model includes co-funding late-stage clinical trials and new product launches in exchange for future royalties, as well as acquiring existing royalties from innovators. The announcement also highlights Royalty Pharma’s portfolio of commercial products and development-stage candidates.

▦ Linked Companies